Due to the highly addictive properties of nicotine, a low percentage of users successfully maintain cessation for longer periods of time. This might be linked to neuroadaptations elicited by the drug, and understanding progressive changes in neuronal function might provide critical insight into nicotine addiction. We have previously shown that neurotransmission in the nucleus accumbens (nAc), a key brain region with respect to drug reinforcement and relapse, is suppressed for as long as seven months after a brief period of nicotine treatment. Studies were therefore performed to define the temporal properties of these effects, and to assess behavioral correlates to altered neurotransmission. Ex vivo electrophysiology revealed progressive depression of synaptic efficacy in the nAc of rats previously receiving nicotine. In addition, following three months of nicotine withdrawal, the responses to GABA A receptor modulating drugs were blunted together with downregulation of several GABA A receptor subunits. In correlation to reduced accumbal neurotransmission, a reduced anxiety-like behavior; assessed in the elevated plus-maze and marble burying tests, were identified in animals pre-treated with nicotine. Lastly, to test the causal relationship between suppressed excitability in the nAc and reduced anxiety-like behavior, rats received local administration of diazepam in the nAc while monitoring behavioral effects on the elevated plus-maze. These results show that nicotine produces long-lasting changes in the GABAergic system, which are observed first after extended withdrawal. Our data also suggest that nicotine produces a progressive suppression of accumbal excitability, which could result in behavioral alterations that may have implications for further drug intake.
Introduction
Smoking cessation is one of the most important strategies for promoting global health. Nonetheless, the mechanisms by which tobacco's main addictive component, nicotine, produces acute and long-lasting effects on the brain are only partly understood. In the central nervous system (CNS) the reinforcing and rewarding properties of nicotine have been attributed to its activation of nicotinic acetylcholine receptors (nAChRs) in the ventral tegmental area (VTA), which modulate the activity of projecting dopamine neurons and thereby also dopamine levels in selective striatal subregions, e.g. in the nucleus accumbens (nAc) (De Biasi and Dani, 2011; Pontieri et al., 1996; Schilstrom et al., 2000; Zhou et al., 2001 ). Several mechanisms underlying nicotine's complex dopamineenhancing effects have been postulated, including a presynaptic facilitation of glutamate release onto dopaminergic cells (Schilstrom et al., 1998) , direct stimulatory effects on dopamine cell bodies (Pidoplichko et al., 2004) , or disinhibition of these neurons through decreased GABAergic interneuron activity due to a direct desensitization of nAChRs on GABAergic interneurons in nAc or on b2 containing nAChRs in the VTA (Mameli-Engvall et al., 2006; Mansvelder and McGehee, 2002; McClure-Begley et al., 2009) . While the dopaminergic mechanisms have gained much attention in the field (Dani and Bertrand, 2007; Le Foll et al., 2003; Molander and Soderpalm, 2003; Morud et al., 2016; Robinson and Berridge, 1993) , studies of the impact of nicotine on g-amino butyric acid (GABA) release and GABA receptors have been more sparse (Hernandez-Vazquez et al., 2014; Vlachou et al., 2011) . GABA can be co-released at dopaminergic terminals (Nelson et al., 2014) , and nicotine may facilitate GABA release directly through presynaptic activation of nAChRs on GABAergic terminals (Hernandez-Vazquez et al., 2014) . A functional upregulation of nAChRs in mesolimbic pathways after chronic nicotine exposure appears to be limited to midbrain GABAergic neurons (Nashmi et al., 2007; Xiao et al., 2009) , and considering that GABAergic neurotransmission exerts a tonic inhibition on dopaminergic neurotransmission (Adermark et al., 2011a) , nicotine may modulate dopaminergic signaling through GABAergic neurotransmission.
Drugs of abuse, including nicotine, have been shown to induce progressive neuroadaptations in selective striatal circuits during protracted drug taking, and withdrawal Belin and Everitt, 2008; Willuhn et al., 2012) . This process appears to follow a temporal-dependent pattern for nicotine, in which protracted withdrawal might have an important part . Whether these effects are induced by the withdrawal period itself, or if nicotine initiates effects that continue to develop over time, is currently not known. In fact, synaptic efficacy in nAc remains suppressed in rats exposed to nicotine seven months earlier, suggesting that nicotine-induced changes in neurotransmission might be life-long . In addition, the specific effect protracted nicotine withdrawal has on GABAergic transmission and behaviors related to GABAergic transmission, such as anxiety-like behaviors, is not well understood. Even though several studies have shown that both acute and chronic nicotine can influence these types of behaviors (Ericson et al., 2000b; Kolokotroni et al., 2011; Olausson et al., 2001a Olausson et al., , 1999 Olausson et al., , 2001b , the molecular events inducing the behavioral effect are more enigmatic.
In order to define the time-scale for nicotine-induced neuroadaptations in nAc, a brain region heavily implicated in reward and addiction (Di Chiara and Imperato, 1988) , we explored if a threeweek non-volitional nicotine exposure period would be sufficient to induce changes in accumbal neurotransmission, without being obscured by effects induced by voluntary drug-seeking behaviors in a self-administration paradigm. Using this experimental setup we sought to test the hypothesis that long-term nicotine withdrawal induces alterations in accumbal GABAergic function and GABArelated behavior with implications for increased risk of relapse and future drug intake.
Material and methods

Animals
The Ethics Committee for Animal Experiments, Gothenburg, Sweden, approved all animal experiments. Male Wistar rats, weighing 260e280 g at the start of the experiment were supplied by Taconic (Ejby, Denmark) and used in chronic nicotine experiments and electrophysiology experiments. All animals were grouphoused in a standard animal care facility with a 12-h light/dark cycle with free access to water and food and were allowed one week of adaption before the start of experiments.
Experimental design
A total of 211 animals, housed in groups of three, were used. Half of these were injected with nicotine (0.36 mg/kg s.c, dissolved in 0.9% NaCl, pH adjusted to 7.2e7.4 with NaHCO 3 ) daily during three weeks and the other half with vehicle (0.9% NaCl). Behavioral sensitization to the locomotor-stimulatory properties of nicotine was confirmed by monitoring drug-induced locomotion (see 2.6.1 Locomotor activity, and supplementary material S2). After the threeweek long drug administration period, four different withdrawal periods (1 week, 1 month, 2 months and 3 months) were initiated and the subjects were tested at the end of each withdrawal period in the elevated plus-maze (see Fig. 1 for experiment outline). Different batches of animals were used for each withdrawal period. The experimenters were blinded to the treatment groups throughout all testing.
Electrophysiology
Brain slice preparation
Coronal brain slices containing the striatal nucleus and the overlaying cortex were prepared from nicotine sensitized rats (supplementary material S2) and vehicle control rats, as previously described (Adermark et al., 2011a) . In brief, animals were anesthetized before decapitation; the brains were quickly dissected and submerged in ice-cold modified artificial cerebrospinal fluid (aCSF) (in mM; 194 sucrose, 30 NaCl, 4.5 KCl, 1 MgCl 2 , 26 NaHCO 3 , 1.2 NaH 2 PO 4 , 10 D-glucose) for 5 min before sectioned coronally in 350 mm thick slices. Brain slices were allowed to equilibrate for at least 1 h at room temperature in regular aCSF solution (in mM; 124 NaCl, 4.5 KCl, 2 CaCl 2 , 1 MgCl 2 , 26 NaHCO 3 , 1.2 NaH 2 PO 4 , 10 Dglucose, continuously bubbled with a mixture of 95% O 2 /5% CO 2 gas) before transferred to the recording chamber.
Striatal field potential recordings
Field potential recordings were performed as previously described (Adermark et al., 2011b) . In brief, population spikes (PS) were activated locally in the nAc shell with stimulus intensity set to yield a PS amplitude approximately half the size of the maximal evoked response, delivered at a frequency of 0.05 Hz. After monitoring a stable baseline for 10 min slices were treated with bicuculline (dissolved in DMSO to 100 mM and diluted aCSF to 20 mM) or muscimol (dissolved in H 2 O to 50 mM and diluted in aCSF to 1 mM). In a subset of recordings differences in input-output function were evaluated by stepwise increasing afferent stimulation strength.
Patch-clamp recordings
Slices were perfused (2e3 ml/min) with aCSF containing (in mM): 1.25 NaH 2 PO 4 , 124 NaCl, 26 NaHCO 3 , 3 KCl, 2 MgCl 2 , 2 CaCl 2 and 10 D-glucose. Medium spiny neurons were visually identified using infrared differential interference contrast video microscopy mounted on a Nikon E600FN microscope. Whole-cell patch-clamp recordings were performed with a patch clamp amplifier (EPC-9, Heka Elektronik, Lambrecht, Germany) at a sampling frequency of 10 kHz and filtered at 2.9 kHz. The neurons were voltage clamped at À70 mV to record spontaneous excitatory postsynapatic currents (sEPSCs) and at 0 mV to record spontaneous inhibitory postsynapatic currents (sIPSCs). The pipette solution contained (in mM): 130 Cs-methanesulfonate, 2 NaCl, 10 HEPES, 0.6 EGTA, 5 Qx-314, 4 Mg-ATP and 0.4 GTP (pH 7.3, adjusted with D-gluconic acid). Patch pipettes (borosilicate, OD 1.5 mm, ID 0.86 mm) were pulled with a horizontal Flaming/Brown micropipette puller (P-97, Sutter Instrument Company, Novato, CA, USA) and they had a resistance of 3.0e6.5 MU. Series resistance was monitored using a 10 mV hyperpolarizing pulse and there were no differences in the average series resistance between the different groups. All recordings were performed at 30 C. Analysis of sEPSCs and sIPSCs was performed using the Mini Analysis Program (version 5.6.28, Synaptosoft Inc, Fort Lee, NJ, USA).
Spine density
Rats were intracardially perfused with NaCl (0.9%) and paraformaldehyde (4%). Brains were incubated in a Golgi-Cox fast kit (FD NeuroTechnologies Inc, Columbia MD, USA) for three weeks, cut at 60 mm using a Leica VT 1200S vibratome (Leica Biosystems GmbH, Wetzlar, Germany) and stained accordingly to the company protocol. An Olympus BX60 microscope (Olympus Corp. PA, USA) was used to identify the nAc and medium spiny neurons of this area for further analysis, and a 100Â oil objective (NA 1.3) and cellSens image analysis software was used to capture images from the distal dendrites (third order or greater). For the dendrite to be included it needed to be well stained and the dendritic tree clearly visible (Li et al., 2003) . Three cells per hemisphere were counted and counting was done blind to treatment by at least two investigators.
Realtime qPCR
Animals were sacrificed and nAc dissected and snap frozen on dry ice. RNA was isolated using RNeasy Lipid Tissue kit (Qiagen, Hilden, Germany) and a total of 800 ng was converted to cDNA using the QuantiTect Reversed Transcription Kit (Qiagen). The quality and quantity of RNA was determined using a NanoDrop 2000 (Thermo Fisher Scientific, Wilmington, DE, USA). Expression of target genes (Gabra1, Gabra2, Gabrb2, Gabrd2, Gabrg2 and SLC6A1) normalized against three reference genes (RPL-1, RPL-19 and HPRT, all primers from Qiagen, QuantiTect Primer assay). qPCR reactions were performed using the QuantiFast SYBR Green Master Mix (Qiagen) in a LightCycler ® 480 PCR System (Roche Applied Science, Indianapolis, IN, USA). The data was analyzed in LightCycler ® 480 software (version 1.5).
2.6. Behavioral testing 2.6.1. Locomotor activity During the nicotine treatment period all animals were tested for changes in locomotor activity once weekly for three weeks. The locomotor activity was performed as previously described (Ericson et al., 2000a; Morud et al., 2016) . Briefly, the rats were habituated during 30 min in the locomotion test box (Kungsbacka m€ at-och reglerteknink AB, Kungsbacka, Sweden), before receiving an injection of nicotine or NaCl s.c, after which the animals were replaced in the testing box for an additional 30 min.
Studies of anxiety-like behaviors
The elevated plus-maze and the marble burying test were used for testing the influence of nicotine treatment on anxiety-like behaviors, as well as investigating if a correlation between decreased accumbal neurotransmission and behavior could be observed. The elevated plus-maze apparatus consisted of black acrylic plastic with two open arms measuring 10 Â 50 Â 1 cm and two closed arms measuring 10 Â 50 Â 40 cm, which was elevated 1 m above the floor (Med Associates, St Albans, VT, USA). The animals were allowed 30 min of habituation to the testing room prior to the start of experiment, after which they were placed in the center of the maze facing an open arm. The marble burying arenas consisted of translucent acrylic boxes (40 Â 40 Â 40 cm), filled with wooden chip bedding material (10 cm thick layer). The bedding material was replaced each time before placing a new animal in the arena. Nine ceramic marbles (Ø 1 cm) were placed in a squared pattern evenly distributed across the testing arena. The animals were allowed two days of habituation testing, 30 min testing each day, before being scored on their behavior on day three during 15 min. The number of marbles buried more than 2/3 was scored, as well as the movements of the marbles. The testing was monitored using the AnyMaze video tracking system (Stoelting Europe, Dublin, Ireland), and the results were scored blind to treatment.
In addition, a subset of drug naïve animals, weighing 280e330 g, was injected with a benzodiazepine, diazepam 20 mg (dissolved in sham solution, consisting of 10% 95-ethanol, 40% propylene glycol, 50% Ringer's solution) into the nAc prior to testing on the elevated plus-maze as described in (Chau et al., 2010) . In brief, injections were given via guide cannula (Plastics One Inc, Roanoke, VA, USA), which were implanted bilaterally into the nAc (AP:þ1.7, ML:±1,4, DV: À8.0) during isoflurane (Baxter, Apoteket AB, Stockholm, Sweden) anesthesia one week before experiments. Each animal was given a total volume of 1 ml/hemisphere (perfusion rate 0.5 ml/ min) of either active substance or control solutions. Before placement on the maze, the animals were placed in an unfamiliar environment for 5 min for drug incubation and for stimulating exploratory behavior. Each animal was tested for 5 min on the maze, only when all four paws had crossed over into any of the arms an entry was recorded.
Statistics
Data is presented as mean values ± SEM, the level of significance was set to p < 0.05. Group effects and treatment effects were analyzed using an unpaired t-test and one or two-way ANOVAs with multiple testing utilizing a Sidak's multiple comparison test. Electrophysiology data was analyzed with Clampex 10.1 (Molecular Devices, Foster City, CA). All analysis was done in GraphPad Prism 6 (GraphPad Software, Inc., San Diego, CA, USA).
Results
Extended nicotine withdrawal induces progressive neuroadaptations in nAc
To establish the time course for non-volitional nicotine-induced changes in accumbal neurotransmission, electrophysiological recordings were performed at several time points during a three months withdrawal period. Golgi staining was performed in a subset of animals to monitor changes in spine density. Neuronal excitability was assessed by measuring field potentials evoked by different stimulation intensities. A progressive decline in response amplitude was seen in brain slices from nicotine treated rats during protracted withdrawal, as compared to vehicle treated rats housed in parallel (Two-way ANOVA, acute: F (1,88) , 0.16, P > 0.05; 1 month: F (1,48) , 0.10, P > 0.05; 2 months: F (1,41) , 1.96, P > 0.05; 3 months: F (1,61) , 4.65, P < 0.05) (Fig. 2AeD ). This progressive decline in synaptic efficacy was concomitant with an increase in paired-pulse ratio (PPR), indicating a reduced probability for transmitter release (unpaired t-test: 1 months PPR: t ¼ 1.56, df ¼ 55, P > 0.05; 3 months PPR: t ¼ 3.92, df ¼ 29, P < 0.001) (Fig. 2EeF) . In contrast, Golgi staining revealed a significant increase in spine density following 3 months of withdrawal (unpaired t-test: 1 months #spines: t ¼ 1.29, df ¼ 90, P > 0.05; 3 months #spines: t ¼ 2.72, df ¼ 70, P < 0.01) (Fig. 2GeH ), indicating that a brief period of intermittent exposure to nicotine followed by withdrawal may promote both synaptic and structural plasticity. Whole cell recordings were performed to more selectively access changes in excitatory and inhibitor activity. Acutely after nicotine treatment, sIPSC amplitude was significantly enhanced unpaired t-test: Acute: sEPSC; amplitude P > 0.05 (t ¼ 1.75, df ¼ 11), sIPSC; amplitude P > 0.05 (t ¼ 2.91, df ¼ 15) (Fig. 2M) . Following three months of withdrawal, there was instead a significant decrease in sIPSC amplitude, indicating that nicotine withdrawal produces progressive adaptations in especially inhibitory neurotransmission 3 months: sEPSC; amplitude P > 0.05 (t ¼ 0.03, df ¼ 18), sIPSC; amplitude P < 0.001 (t ¼ 4.69, df ¼ 21) (Fig. 2N) . Neither sEPSC nor sIPSC frequency was modulated at the different time-points assessed (data not shown).
Extended nicotine withdrawal causes gradual transformations in GABAergic subunit composition and GABAergic neurotransmission
In order to investigate if the reduction in sIPSCs amplitude could be connected to a decreased GABA A receptor expression, qPCR was used for measuring mRNA expression of GABA A receptor subunits. The results show that after two months of nicotine withdrawal the expression of one GABA A subunit was increased (upregulation of alpha 1: Sidak's multiple comparison test, alpha 1 two months : t ¼ 3.19, df ¼ 81, P < 0.01) ( Table 1) . Following three months of withdrawal several GABA A subunits were downregulated in addition to downregulation of the GABA transporter 1 (GAT-1): (Sidak's multiple comparison test, beta 2 three months : t ¼ 3.64, df ¼ 81 P < 0.01; delta three months : t ¼ 3.66, df ¼ 81 P < 0.01; gamma 1 three months : t ¼ 4.28, df ¼ 81, P < 0.001; GAT-1 three months : t ¼ 6.03, df ¼ 81, P < 0.0001) (complete dataset in Supplementary data 1).
GABAergic transmission exerts a powerful control over accumbal dopamine levels and synaptic output, and might underlie the temporal changes in input/output function, as well as the behavioral adaptations, presented here. In order to define if previous nicotine treatment, and the detected downregulation of GABA A subunits, influenced GABAergic neurotransmission, accumbal field potentials were recorded during perfusion of GABA A acting drugs. The GABA A receptor antagonist bicuculline (20 mM) disinhibited accumbal output in a manner that was significantly reduced following two and three months of withdrawal, although the effect was gone after seven months of withdrawal (two-way ANOVA: two months: F (1,19) , 4.45, P < 0.05; three months: F (1,30) , 8.3, P < 0.01; seven months: F (1,25) , 3.99, P > 0.05) (Fig. 3AeE) . The response to the GABA A receptor agonist muscimol (1 mM) was significantly suppressed in the acute phase and after one and three months of withdrawal. Together this indicates that both extrasynaptic levels of GABA and GABA A receptor expression might be altered over the time course of protracted withdrawal. Interestingly, the response to muscimol was significantly reversed after seven months of withdrawal, as displayed by increased excitation (two-way ANOVA, acute: F (1,17) : 6.98, P < 0.05; one months: F (1,17) , 16.8, P < 0.001; three months: F (1,13) , 15.01, P < 0.01; seven months: F (1,13) , 12.03, P < 0.01) (Fig. 3FeJ) . The reversed effect to muscimol after seven months might indicate that the GABA A receptor function has developed a switch in signaling properties, as previously has been described after opiate exposure (Laviolette et al., 2004; Vargas-Perez et al., 2009 ).
Extended nicotine withdrawal influences anxiety-like behaviors
Systemic injections with benzodiazepines, or nicotine, have previously been shown to influence the activity on the elevated plusmaze in drug naïve animals (Olausson et al., 2001b; Pellow and File, 1986) . The effect previous nicotine exposure, together with repeated withdrawal periods, has on this behavior is largely unknown. In relation to data gained from the electrophysiological experiments, we wanted to test if a relationship could be found between this data and the behavior on the elevated plus-maze following extended nicotine withdrawal. We found that intermittent nicotine exposure (sufficient for inducing robust locomotor sensitization, RM two-way ANOVA: nicotine 1st vs. nicotine 15th injection: F (1,34) , 125.8, P < 0.0001, Supplementary data 2) reduced anxiety-like behavior, as measured on the elevated plus-maze, two and three months into nicotine withdrawal (Fig. 4) . The effect developed progressively and the full effect was seen first after three months of nicotine withdrawal, when a significant effect was detected both in time spent on open arms and in number of entries made into open arms (Fig. 4D, H (Fig. 4AeH) .
To further support a change in anxiety-like behavior after three months of withdrawal, the animals were tested in the marble burying test since the willingness to bury and remove marbles has often been interpreted as signs of anxiety (Borsini et al., 2002; Farkas et al., 2017) . We found that nicotine pre-treated animals showed a significantly decreased interest in removing marbles three months into withdrawal, which could be interpreted as a reduced anxiety-like behavior (Fig. 4J ). However no effect was seen in actual marble burying (unpaired t-test: number of marble buried: P > 0.05, t ¼ 0.8, df ¼ 16, marble activity: P < 0.05, t ¼ 2.22, df ¼ 16) (Fig. 4IeJ) . Together the data indicates that extended withdrawal from nicotine influences anxiety-like behaviors, which could derive from suppressed neurotransmission in nAc, and/or an altered GABAergic signaling.
Local GABAergic manipulation in nAc influences an anxiety-like behavior
In order to test if a behavioral correlate to the electrophysiological data and the spontaneous behavior on the elevated plusmaze could be produced by altering local GABAergic transmission, we performed local accumbal injections with the benzodiazepine diazepam. Time spent on the open arms of an elevated plus-maze is closely related to GABAergic function (Pellow and File, 1986) . A-D) Three months into nicotine withdrawal a significant decline in input/output function was detected in the nAc. At the same time point (3 months withdrawal) a reduction in transmitter release probability was detected by a significantly increased PPR (F) together with an increased spine density in the nAc (H). I-L) Micrographs of representative Golgi staining in nAc for each treatment and time point (scale bar: 30 mM). Whole cell recordings at two different time points revealed that nicotine treatment acutely affects sIPSCs by increasing the amplitude when compared to vehicle treated animals (M), whereas protracted nicotine withdrawal influences spontaneous inhibitory function by reducing current amplitude (N). O-P) Example traces showing spontaneous excitatory firing or inhibitory firing of a medium spiny neuron in nAc of vehicle or nicotine treated animals, calibration: (acute) 10 pA, 0,5 s, n ¼ 8e15, (3 months) 20 pA, 0,5 s, n ¼ 8e11. Error bars represent SEM, significant effect by treatment (*P < 0.05, **P < 0.01, ***P < 0.001). Table 1 GABA A related subunit expression as measured by qPCR during protracted withdrawal. After two months of nicotine withdrawal the alpha1 subunit was significantly upregulated, compared to controls, whereas after three months of withdrawal the beta2, delta and gamma1 subunits together with the GABA transporter GAT-1 were significantly downregulated. (**) ¼ significant upregulation, ** ¼ significant downregulation, ns ¼ no significant difference, (**P < 0.01, ***P < 0.001). See Supplementary dataset 1 for complete data. (Fig. 5b) . None of the treatments had any influence on the activity on the closed arms ( Fig. 5c-d) . Interestingly the sham solution containing ethanol had a partial effect on the open arm activity. The slight behavioral effect from the sham solution could be due to an interaction on GABA A receptors by the ethanol content, which would be further intensified with the addition of a benzodiazepine. The results indicate that manipulation of accumbal GABAergic transmission can influence anxiety-like behaviors as assessed on the elevated plus-maze.
Discussion
Here we report that nicotine induces a progressive decline in accumbal synaptic efficacy, which is concomitant with alterations in GABA A receptor subunit gene expression together with an altered ex vivo response to GABA A acting drugs. In parallel, during extended nicotine withdrawal anxiety-like behavior on the elevated plus-maze, and in the marble burying test, decreased spontaneously. In support of a causal relationship between altered accumbal neurotransmission and anxiety-like behavior, we also show that local injection of diazepam into the nAc, which should depress neurotransmission, increases open-arm entries in the elevated plus-maze. The association between GABAergic transmission and nicotine is currently unclear, and to what extent protracted nicotine withdrawal influences behavior is not known. Increased knowledge of these processes could be important for understanding the difficulties met in upholding nicotine cessation or how nicotine acts as a gateway drug (Levine et al., 2011) .
During the protracted nicotine withdrawal we found a progressive development of decreased synaptic activity in nAc. In addition, a delayed effect by nicotine was found on transmitter release and spine density, where previously nicotine treated animals had a decreased probability for transmitter release and an increased spine density after three months of withdrawal. This is similar to what has been reported for dorsal striatum , and it would thus support the hypothesis that nicotine initiates long-lasting effects that continue to develop during the course of extended withdrawal. The discrepancy between the decreased synaptic activity and an increased spine density could also be suggestive of the development of AMPA receptor-silent excitatory synapses, which recently has been reported after both cocaine and morphine exposure (Graziane et al., 2016) . Interestingly, inhibition of the formation of silent synapses within nAc blocks cocaine sensitization (Brown et al., 2011) , suggesting that structural plasticity is crucial for behavioral sensitization. Cocaine also modulates glutamatergic inputs from the amygdala to nAc (MacAskill et al., 2014) , and since the nicotine-induced neuroadaptations observed resemble those of cocaine it might be suggested that glutamatergic input is affected in a temporal dependent manner. However, GABAergic transmission influences excitatory output to a large extent (Gittis et al., 2010; Plotkin et al., 2005) , and therefore the effects observed might also involve progressive changes in GABAergic activity.
Whole cell patch-clamp recordings revealed increased sIPSC amplitude in the acute withdrawal phase in slices from nicotine treated rats, suggesting an enhanced postsynaptic response, possibly connected to an increased GABA A receptor population (Semyanov et al., 2004) . This finding is in line with previous data showing augmented GABAergic inhibition on to dopaminergic neurons, and suppressed sEPSC frequency in MSNs from chronically nicotine treated mice (Xiao et al., 2009 ). An acute increase of evoked IPSCs frequency in striatal MSNs has previously been reported after chronic nicotine exposure in mice (Miura et al., 2006) . The present data also show a progressive effect on GABA A receptor gene expression, in which several subunits together with GAT-1 were significantly downregulated after a three-month withdrawal. Extended withdrawal also reduced sIPSC amplitude, which A-E) The response to the GABA A antagonist bicuculline (20 mM) was altered in a progressive manner during nicotine withdrawal, and after three months the response was depressed (E). F-J) Synaptic depression induced by the GABA A receptor agonist muscimol (1 mM) was significantly reduced in the acute phase (F), and after one (G) and three months (I) of nicotine withdrawal. After seven months of withdrawal the response to muscimol was reversed and induced excitation (J). Time course graphs show mean evoked PS amplitude as compared to baseline with SEM. Significant effect by treatment (*P < 0.05, **P < 0.01, ***P < 0.001).
taken together with the mRNA data may suggest that the expression of GABA A receptors on postsynaptic MSNs is suppressed following protracted withdrawal.
Field potential recordings at different time points after nicotine withdrawal showed a gradual transformation in the response to GABAergic drugs. In the acute phase, a suppressed response to the GABA A agonist muscimol was detected, which could indicate that GABA levels are increased during the initial phase of withdrawal. Even though unaltered sIPSC frequency during the initial withdrawal phase argues against this interpretation. After three months of withdrawal field recordings showed a suppressed response to both a GABA A antagonist and agonist. In addition, whole cell recordings at this time point showed suppressed sIPSC amplitude. Thus, there appears to be both a blunted response to GABA A receptor activation as well as reduced tonic inhibition after three months of withdrawal. Surprisingly, after a seven-month withdrawal period the response to muscimol was inverted in nicotinetreated animals, and instead of the expected inhibition -a slight increase in excitation was detected. Several possible mechanisms could explain this data, such as a switch in GABA A signaling properties, from inhibitory to excitatory, which has been described previously for VTA GABA A receptors after opiate exposure and also after brief opiate withdrawal (Laviolette et al., 2004; Vargas-Perez et al., 2009 ). This effect could also be due to alterations on specific cell populations that would shift the balance of the accumbal circuit. However, these phenomena need to be further addressed before making any conclusions regarding a switch in signaling function.
Since acute nicotine has been shown to influence the activity on the elevated plus-maze, we investigated if extended nicotine withdrawal influenced this anxiety-like behavior. We tested the behavior of nicotine-treated animals, and controls, at different time points during protracted nicotine withdrawal. The data presented here indicates that the behavioral effects by nicotine are consolidated during extended withdrawal. Importantly, the behavioral testing was performed with no drug on board, and several months into withdrawal. No significant effect was observed after one week of withdrawal, but a progressive increase in open arm activity was recorded during nicotine withdrawal. The effects were significant after two and three months of nicotine withdrawal. The reduced anxiety-like behavior seen on the elevated plus-maze, was also detected in another anxiety-like behavior test e the marble burying test, in which the nicotine treated animals displayed a reduced interest for removing the marbles. Interestingly, nicotine appears to display a bimodal effect on anxiety-related behaviors in the acute exposure phase (File et al., 1998) , such that low doses of nicotine induce anxiolytic-like effects and high doses cause anxiogenic-like effects (File et al., 1998; McGranahan et al., 2011; Ouagazzal et al., 1999) . Increased open arm activity on the elevated plus-maze has been associated with reduced anxiety, but it has also been connected to impulsive-or explorative-like behaviors (Gass et al., 2014) . The ability of nicotine to influence these behaviors has previously been investigated mostly in the acute withdrawal phase or directly after first exposure (Kolokotroni et al., 2011; Olausson et al., 2001b) , where the effect on anxiety depends on the number of nicotine exposures and the time since last exposure. This effect thus appears to be reversed in our model during the course of extended withdrawal, following a previously intermittent nicotine treatment. The nicotine-modulating effects on anxiety-like behaviors have also been shown in human studies, in which nicotine acutely induces anxiolytic-like effects in chronic users, whereas acute withdrawal from nicotine instead increases anxiety (Pomerleau and Pomerleau, 1987; West and Hajek, 1997) . The influence of extended nicotine withdrawal on these behaviors in humans is currently not known.
To investigate a potential correlate between anxiolytic-like behavior on the elevated plus-maze and accumbal neurotransmission, drug-naïve animals were injected locally in nAc with the benzodiazepine diazepam. Diazepam's main mechanism of action is to activate GABA A receptors. Such GABA A receptor activation should reduce accumbal neurotransmission e which would resemble the scenario after three months of nicotine withdrawal. The injections increased both open arm entries and the time spent on the open arms. This experiment thus indicates that decreased accumbal neurotransmission and/or changes in GABAergic transmission indeed can produce the same type of behavior as progressively induced by nicotine withdrawal. This is in accordance with recent reports implying the involvement of nAc, as well as GABAergic mechanisms, in these types of behaviors (Feja et al., 2014; Hayes et al., 2014) . Nicotine increases the activity of the central amygdala (Pagliusi et al., 1996) , a region highly implicated in anxiety (Johnson et al., 1994; Kalin et al., 2004; Koob, 2003) . Nicotine-induced effects in the amygdala might thus indirectly regulate accumbal function (Zarrindast et al., 2013) . Interestingly, a local nicotine injection into amygdala causes anxiogenic-like effects in the elevated plus-maze (Zarrindast et al., 2012) . This anxiogenic-like effect has been concluded not to derive from altered GABAergic function within the central amygdala, as the nicotine-induced behaviors cannot be manipulated by local GABA A agonist or antagonist injections (Zarrindast et al., 2008) . Considering that nAc is innervated by amygdala this further demonstrates the specificity of the present accumbal GABAergic manipulation in influencing the behavior in the elevated plus-maze.
In conclusion, nicotine produced progressive and temporaldependent effects on neurotransmission in nAc, in which previous nicotine treatment induces depressing effects on synaptic activity. This effect is accompanied by progressive changes in GABA A receptor subunit expression and altered sensitivity to GABA A active Fig. 5 . Local diazepam injection influences the activity on the elevated plus-maze. A-D) Injection of the benzodiazepine diazepam into nAc influenced anxiety-like behavior, as measured on the elevated plus-maze, by significantly increasing the activity on the open arms as compared to Ringer injected controls, but did not influence the performance on the closed arms. E-G) The graphical brain sections describe the end position of each guide cannula, H) the tissue example demonstrates the impact made in the surrounding tissue by the cannula. n ¼ 10e12/group, error bars represent SEM, significant effect by treatment (*P < 0.05, **P < 0.01, ***P < 0.001).
drugs. In addition, the response to the GABA A agonist muscimol is reversed after seven months of withdrawal, which could indicate a switch in receptor signaling properties. We also describe a role for accumbal GABAergic transmission in anxiety-like behaviors and that progressive changes in accumbal GABAergic neurotransmission develops in parallel with spontaneous anxiolytic-like behaviors in nicotine-treated animals. The neurophysiological and behavioral effects continue to develop over three months of withdrawal. However, the nicotine exposure in the current study was non-volitional, which potentially could be of importance for which neuronal circuits that are recruited and the longevity of these alterations. It is possible that nicotine self-administration could produce more prominent neuroadaptations, although the nonvolitional administration induce protruding changes in neurotransmission that then are independent from alterations related to drug taking behavior. Whether the effects in the current study can be derived from the extended withdrawal period itself, or if it is more related to effects induced already at first nicotine exposure is not known. Therefore, more studies are needed in order to elucidate the mechanism of action and the discrepancy between the effects after nicotine self-administration or non-volitional administration. This study thus describes long-term effects after nicotine exposure on GABAergic mechanisms in nAc, which could be of importance in the development of a nicotine addiction, and that the effects continue to develop during the course of protracted withdrawal.
